Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Zydus Lifesciences Limited (NSE: ZYDUSLIFE), ISIN INE010B01027 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ZYDUSLIFE last traded at ₹1170.10 (+0.67%), with a 52-week range of ₹835.85 to ₹1205.65 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 75.01%, FIIs 6.88%, DIIs 11.27%, mutual funds 5.12%.
EquiSense Score (ECS): 63/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.